What is the appropriate diagnostic and therapeutic approach for a 45-year-old male, vegetarian and non‑alcoholic, with a 7‑day history of acute pain, swelling, erythema, and inability to bear weight on the left great toe, worsened in the morning, and vital signs showing hypertension and tachycardia?

Acute Gout: Diagnostic and Therapeutic Approach

This is acute gout until proven otherwise—immediately aspirate the joint for synovial fluid analysis to confirm monosodium urate (MSU) crystals, and simultaneously initiate anti-inflammatory therapy with NSAIDs, corticosteroids, or low-dose colchicine while awaiting crystal confirmation. 1, 2

Immediate Diagnostic Steps

Step 1: Joint Aspiration (Gold Standard)

Synovial fluid aspiration of the left first metatarsophalangeal (MTP) joint is mandatory to definitively diagnose gout by demonstrating MSU crystals under polarized light microscopy 1. This is the single most important diagnostic test and should be performed before initiating treatment whenever feasible. The aspiration also rules out septic arthritis—a critical differential that requires urgent treatment 3.

• Synovial fluid analysis priorities:
  • Crystal identification under polarized microscopy (needle-shaped, negatively birefringent MSU crystals)
  • Cell count with differential (septic arthritis typically >50,000 WBC/μL, but overlap exists)
  • Gram stain and culture to exclude infection 4, 3

Step 2: Clinical Diagnosis (When Aspiration Not Feasible)

The clinical presentation is highly suggestive of gout based on multiple features 1:

• Monoarticular involvement of first MTP joint (classic "podagra")
• Rapid onset of severe pain (worst within 24 hours)
• Erythema and inability to bear weight
• Early morning aggravation (typical pattern)
• Male gender and cardiovascular risk factors (hypertension present at 140/90)

However, do not diagnose gout based on hyperuricemia alone—serum uric acid can be normal during acute flares 1.

Step 3: Rule Out Septic Arthritis

This is the most critical pitfall. Septic arthritis can present identically and causes permanent joint destruction if untreated 3. The patient's tachycardia (98 bpm) and 7-day duration make infection less likely but not impossible. If joint aspiration shows any concern for infection (positive Gram stain, high suspicion), start empiric antibiotics immediately (typically vancomycin plus ceftriaxone for Staphylococcus aureus and streptococci) 3.

Immediate Therapeutic Management

Acute Flare Treatment (Start Immediately)

Choose one of three first-line options 2:

1. NSAIDs (if no contraindications):

   • Indomethacin 50 mg three times daily, or
   • Naproxen 500 mg twice daily
   • Caution: Monitor renal function and avoid in significant kidney disease

2. Corticosteroids (preferred given hypertension):

   • Prednisone 30-40 mg daily for 5-7 days, then taper
   • Best choice here given cardiovascular comorbidity and vegetarian diet (lower GI bleeding risk concern)

3. Low-dose colchicine:

   • 1.2 mg initially, then 0.6 mg one hour later
   • Then 0.6 mg once or twice daily
   • Strong recommendation for LOW-dose only—high-dose colchicine causes significant toxicity without added benefit 2

Do NOT use combination therapy initially—single-agent treatment is equally effective with fewer adverse effects 2.

Diagnostic Workup (Concurrent with Treatment)

Laboratory Tests

• Serum uric acid (but remember: can be normal during acute attack)
• Renal function (creatinine, eGFR)—chronic kidney disease is a risk factor 1
• Complete metabolic panel
• CBC to assess for infection/inflammation

Imaging (If Crystal Identification Not Possible)

Ultrasound of the affected joint is the preferred imaging modality 1:

• Look for double contour sign (hyperechoic enhancement over cartilage—highly specific for urate deposits)
• Identify tophi not evident on examination
• Plain radiographs have limited value in acute flares but may show chronic changes

Systematic Comorbidity Assessment

All patients with gout require cardiovascular risk stratification 1:

• Hypertension (already present at 140/90—needs management)
• Screen for: diabetes, dyslipidemia, obesity (calculate BMI), chronic kidney disease, ischemic heart disease
• Assess for risk factors for hyperuricemia 1:
  • Medications: diuretics, low-dose aspirin (none reported here)
  • Alcohol consumption (none—good)
  • Diet: excess meat/shellfish (vegetarian—protective), high-fructose beverages

Long-Term Management Decision

Do NOT initiate urate-lowering therapy (allopurinol, febuxostat) during the acute attack or after a first episode 2. This patient has a 7-day history suggesting possibly his first recognized attack.

Criteria for Urate-Lowering Therapy (Future Consideration)

Discuss initiating allopurinol or febuxostat only if 2:

• Recurrent gout attacks (≥2 attacks per year)
• Presence of tophi
• Chronic gouty arthritis
• Uric acid kidney stones

When starting urate-lowering therapy, provide concomitant prophylaxis with low-dose colchicine (0.6 mg daily) or low-dose NSAID for 3-6 months to prevent flares 2.

Common Pitfalls to Avoid

1. Assuming hyperuricemia = gout diagnosis—many people with elevated uric acid never develop gout 1
2. Missing septic arthritis—always consider infection in acute monoarthritis 4, 3
3. Using high-dose colchicine—causes severe GI toxicity without benefit 2
4. Starting allopurinol during acute flare—precipitates worse attacks
5. Ignoring cardiovascular comorbidities—gout patients have increased mortality from CV disease 1

Specific Algorithm for This Patient

1. Aspirate left first MTP joint → send for crystal analysis, cell count, Gram stain, culture
2. Start prednisone 35 mg daily (given hypertension, avoid NSAIDs initially)
3. Check serum uric acid, renal function, metabolic panel
4. Ultrasound left foot if aspiration unsuccessful or atypical features
5. Optimize blood pressure control (currently 140/90)
6. Counsel on lifestyle: maintain vegetarian diet, avoid high-fructose beverages, maintain hydration, weight management
7. Do NOT start allopurinol now—wait to see if attacks recur
8. Follow-up in 2-4 weeks to reassess and discuss long-term prevention if recurrent attacks develop